Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception
  • Published Date:
    Feb 22 2018
  • Source:
    Int J Gynaecol Obstet. 141(3):287-294.
  • Language:
    English
Filetype[PDF-772.30 KB]


Details:
  • Alternative Title:
    Int J Gynaecol Obstet
  • Personal Author:
  • Description:
    Background

    Combined oral contraceptives (COCs) containing various progestogens could be associated with differential risks for venous thromboembolism (VTE).

    Objective

    To evaluate the comparative risks of VTE associated with the use of low‐dose (less than 50 μg ethinyl estradiol) COCs containing different progestogens.

    Search strategy

    PubMed and the Cochrane Library were searched from database inception through September 15, 2016, by combining search terms for oral contraception and venous thrombosis.

    Selection criteria

    Studies reporting VTE risk estimates among healthy users of progestogen‐containing low‐dose COCs were included.

    Data collection and analysis

    A random‐effects model was used to generate pooled adjusted risk ratios and 95% confidence intervals; subgroup and sensitivity analyses assessed the impact of monophasic‐COC use and study‐level characteristics.

    Main results

    There were 22 articles included in the analysis. The use of COCs containing cyproterone acetate, desogestrel, drospirenone, or gestodene was associated with a significantly increased risk of VTE compared with the use of levonorgestrel‐containing COCs (pooled risk ratios 1.5–2.0). The analysis restricted to monophasic COC formulations with 30 μg of ethinyl estradiol yielded similar findings. After adjustment for study characteristics, the risk estimates were slightly attenuated.

    Conclusions

    Compared with the use of levonorgestrel‐containing COCs, the use of COCs containing other progestogens could be associated with a small increase in risk for VTE.

  • Subject:
  • Pubmed ID:
    29388678
  • Pubmed Central ID:
    PMC5969307
  • Document Type:
    Journal Article
  • Funding:
    001/World Health Organization/International
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition
    Personal Author:
    Curtis, Kathryn M.
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    June 18, 2010
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2010; 59(RR-4):1-86.
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-4
    Description:
    "CDC created U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, from guidance developed by the World Health Organization (WHO) and finalized the recommendations after consultation with a group of health professionals who met in Atlanta, G...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.35 MB]
  2. U.S. medical eligibility criteria for contraceptive use, 2016
    Personal Author:
    Curtis, Kathryn M.; Tepper, Naomi K.; Jatlaoui, Tara C.; Berry-Bibee, Erin; Horton, Leah G.; Zapata, Lauren B.; Simmons, Katharine B.; Pagano, H. Pamela; Jamieson, Denise J.; Whiteman, Maura K.;
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.. Division of Reproductive Health.
    Published Date:
    July 29, 2016
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 65, no. 3
    Description:
    The 2016 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) comprises recommendations for the use of specific contraceptive methods by women and men who have certain characteristics or medical conditions. These recommendations for hea...
    Status:
    current
    File Type:
    Filetype[PDF - 1.82 MB]
  3. Coming Soon
    Safety of contraceptive use among women with congenital heart disease: A systematic review
    Personal Author:
    Abarbanell, Ginnie; Tepper, Naomi K.; Farr, Sherry L.;
    Published Date:
    January 25 2019
    Source:
    Congenit Heart Dis. 14(3):331-340
    Description:
    Objective:Women with congenital heart disease (CHD) are at increased risk of pregnancy complications and need information on safe, effective contraceptive methods to avoid unintended pregnancy. This systematic review examines evidence regarding safet...
    Public Access
    Available on:
    May 01, 2020
  4. Contraceptive use among women with multiple sclerosis: a systematic review☆,☆☆
    Personal Author:
    Zapata, Lauren B.; Oduyebo, Titilope; Whiteman, Maura K.; Houtchens, Maria K.; Marchbanks, Polly A.; Curtis, Kathryn M.;
    Published Date:
    July 21 2016
    Source:
    Contraception. 94(6):612-620
    Description:
    Background:Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone ...
    File Type:
    Filetype[PDF - 326.16 KB]
  5. Sexual identity, sex of sexual contacts, and health-related behaviors among students in grades 9–12 — United States and selected sites, 2015
    Personal Author:
    Kann, Laura; Olsen, Emily O'Malley; Harris, William A.; Shanklin, Shari L.; Flint, Katherine H.; Queen, Barbara; Lowry, Richard; Chyen, David; Whittle, Lisa; Thornton, Jemekia; Lim, Connie; Yamakawa, Yoshimi; Brener, Nancy D.; Zaza, Stephanie;
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Adolescent and School Health.
    Published Date:
    August 12, 2016
    Series:
    MMWMMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 65, no. 10
    Description:
    Problem: Sexual identity and sex of sexual contacts can both be used to identify sexual minority youth. Significant health disparities exist between sexual minority and nonsexual minority youth. However, not enough is known about health-related behav...
    File Type:
    Filetype[PDF - 879.66 KB]